Frontlight ResearchEarly access
Childhood cancers trials in United States
933 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleThe OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
- Where
- Canton, Chicago, Dallas, Duarte, Los Angeles, Louisville, Memphis, Omaha, Weeki Wachee, Whittier
- Age
- 12 years to 95 years
- People
- 144
- Run by
- AVM Biotechnology Inc
See details and how to joinNCT04329728 - Phase 1/2Taking peopleAutologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma
- Where
- Valhalla
- Age
- 12 years to 70 years
- People
- 20
- Run by
- New York Medical College
See details and how to joinNCT04491370 - Phase 1/2Not yet taking people in United StatesCD30 CAR T-cells Post AutoHSCT for Poor-risk Hodgkin Lymphoma
- Where
- Valhalla
- Age
- 6 years to 29 years
- People
- 21
- Run by
- New York Medical College
See details and how to joinNCT06617286 - Phase 1/2Taking peoplePhase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
- Where
- Philadelphia
- Age
- 1 month to 25 years
- People
- 100
- Run by
- Children's Hospital of Philadelphia
See details and how to joinNCT06839456 - No phaseTaking peopleMassage Impact on Sleep in Pediatric Oncology
- Where
- Philadelphia, Washington D.C.
- Age
- 12 years to 21 years
- People
- 70
- Run by
- Children's Hospital of Philadelphia
See details and how to joinNCT06892158 - No phaseTaking peopleBrief Title Mechanisms of Cancer-Related Pain and Opioid Use Among Adolescents and Young Adult Sarcoma Survivors: Pilot Feasibility Study
- Where
- Buffalo
- Age
- 12 years to 70 years
- People
- 40
- Run by
- Roswell Park Cancer Institute
See details and how to joinNCT07402577 - Phase 1Taking peopleStudy of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
- Where
- Seattle
- Age
- 1 year to 26 years
- People
- 90
- Run by
- Seattle Children's Hospital
See details and how to joinNCT04185038 - Phase 1Taking peopleUAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy
- Where
- Birmingham
- Age
- 4 weeks to 75 years
- People
- 50
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT06047886 - No phaseTaking peopleMolecular and Genomic Profiling of Head and Neck Tumors
- Where
- The Bronx
- People
- 1,000
- Run by
- Montefiore Medical Center
See details and how to joinNCT00200486 - No phaseTaking peopleProton Therapy Patient Registry
- Where
- Cleveland
- People
- 999
- Run by
- Case Comprehensive Cancer Center
See details and how to joinNCT02986048 - No phaseTaking peopleBacktracking Leukemia-Typical Somatic Mutations in Cord Blood
- Where
- Minneapolis
- Age
- Up to 25 years
- People
- 300
- Run by
- Children's Oncology Group
See details and how to joinNCT05014165 - Phase 2Taking peopleMEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
- Where
- Aurora, Cincinnati, Columbus, Miami, Washington D.C.
- Age
- 1 year to 39 years
- People
- 38 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT05286788 - No phaseNot yet taking people in United StatesLumbar Punctures for the Detection of ctDNA in the Cerebrospinal Fluid of Patients With Stage III and IV Non-Small Cell Lung Cancer
- Where
- Columbus
- People
- 40
- Run by
- Ohio State University Comprehensive Cancer Center
See details and how to joinNCT06816979 - No phaseTaking peopleMultiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)
- Where
- Rochester
- Age
- 8 years to 17 years
- People
- 200
- Run by
- University of Rochester
See details and how to joinNCT06956781 - Phase 1Not yet taking people in United StatesGPC3 CAR T Cells With IL-15 and IL-21 for Recurrent ATRT and CNS Rhabdoid Tumors (RADIANT)
- Where
- Houston
- Age
- 1 year to 21 years
- People
- 21
- Run by
- Baylor College of Medicine
See details and how to joinNCT07513194 - Phase 2Taking peopleMT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
- Where
- Minneapolis
- Age
- Up to 60 years
- People
- 70
- Run by
- Masonic Cancer Center, University of Minnesota
See details and how to joinNCT05735717 - No phaseTaking peopleCommunication Issues in Patient and Provider Discussions of Immunotherapy
- Where
- Atlanta, Decatur
- People
- 125
- Run by
- Emory University
See details and how to joinNCT05873608 - No phaseTaking peopleShwachman Diamond Syndrome Registry and Study
- Where
- Aurora, Boston, Cincinnati
- People
- 5,000
- Run by
- Boston Children's Hospital
See details and how to joinNCT06056908 - No phaseEnrolling by invitationAssessing Perceptions of ML Explanations by Medical Oncologists
- Where
- Philadelphia
- People
- 50
- Run by
- Abramson Cancer Center at Penn Medicine
See details and how to joinNCT06699615 - No phaseTaking peopleStandard-of-Care Reduced-Intensity Conditioning (RIC) With 200 Versus 400 cGy of Total Body Irradiation (TBI) in Patients With Acute Leukemia Undergoing First Allogeneic Blood or Marrow Transplantation (BMT)
- Where
- Baltimore
- People
- 160
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT06803745 - No phaseTaking peopleProspective Sinonasal Cancer Multi-institution Study
- Where
- Rochester
- Age
- 30 days to 99 years
- People
- 200
- Run by
- Mayo Clinic
See details and how to joinNCT04755855 - Phase 2/3Taking peopleA Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- Where
- Atlanta, Aurora, Boston, Chicago, Columbus, Dallas, Durham, Englewood, Germantown, Houston, Iowa City, Jacksonville, Knoxville, La Jolla, Los Angeles, Madison, Miami, Nashville, New York, Palo Alto, Philadelphia, Pittsburgh, Rochester, Scottsdale, Seattle, Washington D.C.
- Age
- 18 years and over
- People
- 280 worldwide
- Run by
- Replimune, Inc.
See details and how to joinNCT06581406 · EU 2023-508784-68-00 - No phaseNot yet taking people in United StatesEvaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration
- Where
- Rochester
- Age
- Up to 21 years
- People
- 20
- Run by
- Mayo Clinic
See details and how to joinNCT07221656 - No phaseTaking peopleMayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study
- Where
- Rochester
- People
- 15,000
- Run by
- Mayo Clinic
See details and how to joinNCT02457962 - No phaseTaking peopleGenerating Novel Therapeutic Strategies Based on Evolutionary Tumor Board
- Where
- Tampa
- People
- 35
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
See details and how to joinNCT04343365